3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
8
Completed
5
Not yet recruiting
2
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
13
Esophageal Squamous Cell Carcinoma
7
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Neoplasms
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of External Auditory Canal
1
Seminoma
1
Recurrence
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Muscle Invasive Bladder Cancer
1
Interventions
Oxaliplatin
13
Bevacizumab
11
Capecitabine
10
Fluorouracil
8
Blood Specimen Collection
8
Leucovorin
7
Cetuximab
7
Folfox protocol
6
pembrolizumab
5
Drug Therapy
5
trifluridine tipiracil drug combination
4
dostarlimab
4
Nivolumab
4
Irinotecan
4
HMPL-013
4
fludarabine
3
XELOX
3
Specimen Handling
3
IFL protocol
3
Cyclophosphamide
3
Biopsy
3
toripalimab
2
tislelizumab
2
tipiracil
2
regorafenib
2
pertuzumab
2
envafolimab
2
encorafenib
2
cemiplimab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Colonic Neoplasms
×
Neoadjuvant Therapy
×
Clear all
NCT06107920
2026-02-10
COnCERTO
University Hospital, Rouen
Phase 3
Recruiting
232 enrolled